
Semaglutide is a GLP-1 receptor agonist, a medication that mimics the action of the GLP-1 hormone to regulate blood sugar and manage appetite. Commonly recognized under brand names like Ozempic, Wegovy, and Rybelsus, it’s a proven option for treating type 2 diabetes and supporting weight loss.
How It Works:
Uses:
Available as weekly injections or daily tablets, Semaglutide is most beneficial when paired with a balanced diet and regular exercise. Always consult a healthcare provider before starting treatment.
Comprehensive Weight Loss Program with Transparent Pricing – Our Semaglutide-based program offers a holistic, doctor-led telehealth experience tailored to your needs. With flat-rate pricing and a focus on comprehensive care, this program supports your journey toward lasting health.
What’s Included:
✓ 4 Weeks of Medication: One price covers all refills and dosages.
✓ Expert Medical Oversight: Continuous support from dedicated healthcare providers.
✓ Biannual Lab Testing: Metabolic evaluations every 6 months to track your progress.
✓ Personalized Nutrition Coaching: Sustainable strategies for long-term health.
✓ Complete Supplies: Includes syringes and alcohol pads for easy at-home injections.
✓ Educational Resources: Access to tools and content to guide your weight loss journey.
Semaglutide is a transformative solution for weight management, shown to help users lose up to 15% of their body weight in just 12 months. When paired with a healthy diet and consistent exercise, Semaglutide delivers remarkable and sustainable results.
Units represent the volume of medication drawn into the syringe.
Milligrams indicate the weekly prescribed dose.
The required units depend on the concentration of the Semaglutide vial being used.
Volume (units) | Dose (mg) | Price per month |
---|---|---|
10 Units | 0.25 mg | |
20 Units | 0.5 mg | |
30 Units | 0.75 mg | |
40 Units | 1.0 mg | |
50 Units | 1.25 mg |
Volume (units) | Dose (mg) | Price per month |
---|---|---|
5 Units | 0.25 mg | |
10 Units | 0.5 mg | |
15 Units | 0.75 mg | |
20 Units | 1.0 mg | |
25 Units | 1.25 mg |
Common side effects include nausea, diarrhea, vomiting, and constipation, which usually subside as your body adjusts. Rare but serious side effects, such as pancreatitis or allergic reactions, can occur. Always discuss potential risks with your healthcare provider.
Semaglutide is generally prescribed for adults with a BMI of 30 or higher or a BMI of 27 or above with related conditions like type 2 diabetes or hypertension. A healthcare provider will assess your medical history to determine eligibility.
Semaglutide is injected under the skin in areas such as the stomach, thigh, or upper arm. It’s essential to rotate injection sites weekly to avoid irritation. Detailed instructions are provided during your consultation.
Yes, Semaglutide prescriptions can be obtained through an online consultation with a licensed healthcare provider. After evaluation, your prescription can be delivered directly to your doorstep.
While Semaglutide promotes weight loss on its own, combining it with regular exercise and a healthy diet can maximize its effectiveness and enhance overall health benefits.
Initial weight loss may be noticeable within the first few weeks, with significant changes often occurring after 3–6 months. Consistency with the treatment and lifestyle changes is key to success.
Discontinuing Semaglutide without a long-term plan may result in weight regain. Your healthcare provider can help you create a sustainable strategy, which may include lifestyle changes or continued treatment.
Fatigue can occur as a side effect due to changes in blood sugar and appetite regulation. If the tiredness persists, consult your healthcare provider for further guidance.
Alicia, an Emmy Award-Winning Visual Effects Artist and founder of The L.A. Glow, worked in the movie business for 15 years.
Essential Information on Medications: Saxenda®, Victoza®, Wegovy®, and Ozempic® are patented products of Novo Nordisk™, while Eli Lilly and Company™ produce Mounjaro™ and Zepbound. This website is not affiliated with, endorsed by, or connected to these companies or their products in any capacity. While these FDA-approved medications may be available through other sources, we do not provide them, and they are currently experiencing supply shortages. During such shortages, pharmacies might prepare compounded versions of these drugs, provided they comply with the Federal Food, Drug, and Cosmetic Act’s requirements. Compounded medications are valuable for patients with unique medical needs that FDA-approved drugs cannot address. However, it is important to note that compounded drugs are not FDA-approved, nor do they undergo premarketing evaluations for safety, effectiveness, or quality. The FDA has not assessed these medications for their intended uses, nor has the manufacturing process for compounded drugs been reviewed by the FDA.
Critical Details About Compounded Semaglutide
Compounded medications are legally allowed to be prescribed under federal law; however, they are not FDA-approved and do not undergo FDA evaluation for safety, efficacy, or production standards. At TheLaGlow, compounded semaglutide is prescribed based on an individualized medical assessment.
WARNING: Potential Risk of Thyroid C-Cell Tumors
Research in animals has linked semaglutide, the active ingredient in some GLP-1 receptor agonists, to thyroid tumors, including medullary thyroid carcinoma (MTC). It is unclear if semaglutide causes similar tumors in humans. Notify your healthcare provider immediately if you notice symptoms of thyroid cancer, such as neck lumps or swelling, hoarseness, swallowing difficulties, or shortness of breath. Compounded semaglutide is not suitable for individuals with personal or family histories of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Uses of Compounded Semaglutide
Compounded semaglutide is intended for use alongside a reduced-calorie diet and increased physical activity to manage chronic weight in adults who meet the following criteria:
Usage Restrictions
Avoid Use If You:
Precautions and Warnings:
Pregnancy and Fertility Considerations
Semaglutide may harm an unborn child. Avoid use during pregnancy or if planning to become pregnant. Stop treatment at least two months before attempting to conceive.
Common Side Effects:
Frequently reported side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, fatigue, headaches, and low blood sugar in patients with type 2 diabetes.
Potential Drug Interactions:
Compounded semaglutide slows gastric emptying, which could impact the absorption of oral medications. Consult your healthcare provider to manage potential interactions effectively.